Senseonics Holdings Inc (NYSEAMERICAN:SENS) was the recipient of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 25,165,859 shares, a decline of 5.3% from the December 14th total of 26,580,670 shares. Currently, 27.7% of the company’s shares are sold short. Based on an average daily volume of 1,514,190 shares, the days-to-cover ratio is currently 16.6 days.

Several hedge funds have recently added to or reduced their stakes in SENS. BlackRock Inc. raised its holdings in Senseonics by 1,958.6% in the second quarter. BlackRock Inc. now owns 3,811,007 shares of the company’s stock worth $15,664,000 after purchasing an additional 3,625,877 shares in the last quarter. Massachusetts Financial Services Co. MA bought a new position in Senseonics in the third quarter worth about $14,703,000. PointState Capital LP bought a new position in Senseonics in the second quarter worth about $10,970,000. Janus Henderson Group PLC bought a new position in Senseonics in the third quarter worth about $12,222,000. Finally, OppenheimerFunds Inc. bought a new position in Senseonics in the second quarter worth about $7,926,000. Hedge funds and other institutional investors own 30.66% of the company’s stock.

SENS stock opened at $2.69 on Friday. Senseonics has a 1-year low of $2.26 and a 1-year high of $5.29.

Senseonics (NYSEAMERICAN:SENS) last released its quarterly earnings data on Thursday, November 8th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.01. The firm had revenue of $5.16 million during the quarter, compared to the consensus estimate of $5.16 million. The business’s revenue was up 145.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.13) earnings per share.

Separately, UBS Group started coverage on Senseonics in a report on Tuesday, November 27th. They issued a “sell” rating for the company. One equities research analyst has rated the stock with a sell rating and six have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $6.00.

TRADEMARK VIOLATION WARNING: “Short Interest in Senseonics Holdings Inc (SENS) Declines By 5.3%” was posted by Daily Political and is owned by of Daily Political. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at

About Senseonics

Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.

See Also: How much can an individual set aside as a catch-up contribution?

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with's FREE daily email newsletter.